2020
DOI: 10.1002/cem.3325
|View full text |Cite
|
Sign up to set email alerts
|

Predicting molecular activity on nuclear receptors by multitask neural networks

Abstract: The interest in multitask and deep learning strategies has been increasing in the last few years, in application to large and complex dataset for quantitative structure-activity relationship (QSAR) analysis. Multitask approaches allow the simultaneous prediction of molecular properties that are related, through information sharing, whereas deep learning strategies increase the potential of capturing nonlinear relationships. In this work, we compare the binary classification capability of multitask deep and sha… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
7
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
4
2
2

Relationship

2
6

Authors

Journals

citations
Cited by 19 publications
(17 citation statements)
references
References 56 publications
(72 reference statements)
2
7
0
Order By: Relevance
“…Approaches based on human-engineered molecular descriptors resulted to outperform deep learning based on graphs or SMILES, with no machine learning strategy being consistently better at handling activity cliffs compared to their absolute performance. Our results corroborate previous evidence showing that deep learning methods do not necessarily hold up (yet) against simpler machine learning methods for drug discovery purposes [15][16][17] . We envision the development of deep learning strategies that are (a) more efficient in low-data scenarios and (b) better suited to capture structure-activity "discontinuities" to be key for future prospective applications.…”
Section: Discussionsupporting
confidence: 90%
See 1 more Smart Citation
“…Approaches based on human-engineered molecular descriptors resulted to outperform deep learning based on graphs or SMILES, with no machine learning strategy being consistently better at handling activity cliffs compared to their absolute performance. Our results corroborate previous evidence showing that deep learning methods do not necessarily hold up (yet) against simpler machine learning methods for drug discovery purposes [15][16][17] . We envision the development of deep learning strategies that are (a) more efficient in low-data scenarios and (b) better suited to capture structure-activity "discontinuities" to be key for future prospective applications.…”
Section: Discussionsupporting
confidence: 90%
“…Most AI breakthroughs in chemistry have been driven by deep learning, based on neural networks with multiple processing layers [12][13][14] . However, there is currently no consensus on whether deep learning models outperform simpler machine learning approaches when it comes to molecular property prediction [15][16][17] . The identification of current gaps in machine/deep learning approaches would allow the development of more reliable and widely applicable models to accelerate molecule discovery.…”
Section: Introductionmentioning
confidence: 99%
“…Approaches based on human-engineered molecular descriptors resulted to outperform deep learning based on graphs or SMILES, with no machine learning strategy being consistently better at handling activity cliffs compared to their absolute performance. Our results corroborate previous evidence showing that deep learning methods do not necessarily hold up against simpler machine learning methods (yet) for drug discovery purposes [15][16][17] . We envision the development of deep learning strategies that are (a) more efficient in low-data scenarios and (b) better suited to capture structure-activity "discontinuities" to be key for future prospective applications.…”
Section: Discussionmentioning
confidence: 99%
“…Most AI breakthroughs in chemistry have been driven by deep learning -based on neural networks with multiple processing layers [12][13][14] . However, there is currently no consensus on whether deep learning models outperform simpler machine learning approaches when it comes to molecular property prediction [15][16][17] . The identification of current gaps in machine and deep learning approaches would allow the development of more reliable and widely applicable models to accelerate molecule discovery.…”
Section: Introductionmentioning
confidence: 99%
“…In this work, each bioactivity type for a given receptor was considered as a task. As in [ 22 ], only active and inactive annotations were considered and tasks containing such annotations for less than 200 molecules were discarded. The considered dataset is therefore composed of a total of 14,963 chemicals annotated (as active or inactive) for at least one of the selected 30 tasks.…”
Section: Methodsmentioning
confidence: 99%